Most Read Articles
4 days ago
Circulating interleukin (IL)-6 correlates with worse baseline haemodynamics and may be indicative of clinical worsening in kids with pulmonary arterial hypertension, a recent study has shown.
Pearl Toh, 13 hours ago
Switching to a single-tablet triple-drug combination comprising bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is well tolerated while continuing to provide virologic suppression through to 48 weeks in elderly people (aged ≥65 years) living with HIV (PLWH), shows a pooled analysis presented at the AIDS 2020 virtual conference.
4 days ago
Patients with erectile dysfunction (ED) have elevated values of atherogenic index of plasma (AIP), a recent study has found.
4 days ago
Despite increased community awareness, diagnostic delays persist among patients with pulmonary arterial hypertension (PAH), claims a recent study, noting that those who experience longer diagnostic interval are at higher risk of mortality.

Product Highlight - Zavicefta

29 Nov 2019

Active ingredient: Ceftazidime (as pentahydrate) equivalent to 2 g and Avibactam (as sodium salt) equivalent to 0.5 g.

Indications: ZAVICEFTATM is indicated in adults for the treatment of the following infections

  • Complicated Intra-Abdominal Infection (cIAI)
  • Complicated Urinary Tract Infection, including Pyelonephritis (cUTI)
  • Hospital-acquired Pneumonia (HAP), including ventilator associated pneumonia (VAP)
  • Infections due to aerobic Gram-negative organisms in patients with limited treatment options
  • Consideration should be given to official guidance on the appropriate use of antibacterial agents. For treatment of cIAI use in combination with metronidazole.

Dosage & Administration: The recommended dosage of ZAVICEFTATM is 1 vial where each vial contains 2 g ceftazidime and 0.5 g avibactam administered by intravenous (IV) infusion in a volume of 100 mL at a constant rate over 120 minutes in patients aged 18 years or older. Treatment is repeated every 8 hours.

Related MIMS Drugs

Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Doctor - Thailand digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
4 days ago
Circulating interleukin (IL)-6 correlates with worse baseline haemodynamics and may be indicative of clinical worsening in kids with pulmonary arterial hypertension, a recent study has shown.
Pearl Toh, 13 hours ago
Switching to a single-tablet triple-drug combination comprising bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) is well tolerated while continuing to provide virologic suppression through to 48 weeks in elderly people (aged ≥65 years) living with HIV (PLWH), shows a pooled analysis presented at the AIDS 2020 virtual conference.
4 days ago
Patients with erectile dysfunction (ED) have elevated values of atherogenic index of plasma (AIP), a recent study has found.
4 days ago
Despite increased community awareness, diagnostic delays persist among patients with pulmonary arterial hypertension (PAH), claims a recent study, noting that those who experience longer diagnostic interval are at higher risk of mortality.